Bureaucrats, checkuser, developer, editor, reviewer, Administrators, widgeteditor
1,951
edits
Changes
no edit summary
{{Drug
| name = Olanzapine
| group = Atypical atypical AP| type = antipsychotic| otheruse = moodstabilizer
| pubchem = 4585
| medscape = 1644
| emea = Zyprexazyprexa| therapy1 ATC = N05AH03| therapyid1 CAS = 132539-06-1| therapyname1 ChemSpiderID = 10442212| therapy2 drugbank = APRD00138| therapyid2 = | therapyname2 drugscom = olanzapine
| ftk = olanzapine
| othername1 metabolization = * Olanzapine is principally metabolized by CYP1A2 and CYP2D6.| other1 start = | otherid1 stop = | other2 equivalent = 0.4| otherid2 equivalent_ref = <ref>Woods SW Chlorpromazine equivalent doses for the newer atypical antipsychotics; ''J Clin Psychiatry'' 2003;'''64''':663-667</ref>| othername2 comparison = haloperidol<!-- | avail = unknown-->| halflife = 32-52| halflife_ref = <ref name="informatorium">{{KNMP|olanzapine}}</ref>| ct = 11| ct_ref = <ref name="informatorium" />| administration = oral| dose = 2.5-20| dose_ref = <ref name="informatorium" />| DDD = 30| DDD_ref = <ref name="informatorium" />| ctox = 100| ctox_ref = {{FTK-TOX}}| <includeonly>| type isswitch = Antipsychotic1 </includeonly>
}}
